Countries finalize historic pandemic agreement after three years of negotiations
https://news.un.org/en/story/2025/04/1162301#pandemictreaty #WHO #access2meds
Countries finalize historic pandemic agreement after three years of negotiations
In the early hours of Wednesday morning in Geneva, countries finalized a draft global agreement aimed at improving how the world prepares for and responds to pandemics, marking a historic step that will be submitted to the World Health Assembly in May for adoption.
UN News‘Half the place would be blown to bits’: the Irish villages under threat from Trump’s tariffs
Cork’s pharmaceutical industry, vital to the local economy, is at risk as US trade policies threaten small towns reliant on the sector
The Guardian
Trump has Australia’s generic medicines in his sights. And no-one’s talking about it
The major parties say they won’t use the PBS as a bargaining chip in US tariff negotiations. They also need to resist pressure to slow down access to generic drugs.
The ConversationTrump flags ‘major tariff on pharmaceuticals’ as trade chief says US ‘running up score’ on Australia
https://www.theguardian.com/australia-news/2025/apr/09/donald-trump-flags-major-tariff-on-pharmaceuticals-as-us-senator-criticises-whack-on-australia US president says he will shortly announce the new tariff on pharmaceuticals but does not give any details.
#trade #access2meds #tariffsTrump flags ‘major tariff on pharmaceuticals’ as trade chief says US ‘running up score’ on Australia
US president says he will shortly announce the new tariff on pharmaceuticals but does not give any details
The GuardianAlbanese tells Trump that Australia is ‘not negotiating’ on biosecurity, medicines and news
https://www.theguardian.com/australia-news/2025/apr/01/australia-us-trump-tariffs-albanese-biosecurity-medicine Office of US trade representative releases report on ‘foreign trade barriers’ including Australia’s biosecurity regime for imported beef, pork and poultry
#trade #auslaw #auspol #uslaw #uspol #AUSFTA #access2meds #agriculture #mediaAlbanese tells Trump that Australia is ‘not negotiating’ on biosecurity, medicines and news
Office of US trade representative releases report on ‘foreign trade barriers’ including Australia’s biosecurity regime for imported beef, pork and poultry
The GuardianThe European Patent Office declared a patent owned by CureVac valid, after a challenge from drugmaker BioNTech, the company said
https://uk.finance.yahoo.com/news/european-patent-office-declares-curevac-222223670.html #patent #COVID19 #access2meds
European Patent Office declares CureVac mRNA patent valid
The European Patent Office declared a patent owned by CureVac valid, after a challenge from drugmaker BioNTech, the company said on Thursday. U.S.-listed...
Yahoo FinanceBig pharma is taking aim at Australia’s PBS. Could Trump force us to pay more for medicines?
Big pharma US wants to sell more drugs in Australia for more and its demands are now entangled with the ongoing trade tariff war
The Guardian'For a nation at the forefront of medical innovation and drug manufacture, vast numbers of Americans simply can't afford to access to vital medicines.'
https://www.abc.net.au/news/2025-03-21/behind-americas-decades-long-fight-to-dismantle-the-pbs/105078864 #patent #access2meds #auspol #uspol #IP #health
Behind America's decades-long fight to dismantle the PBS
America's pharmaceutical giants have been plotting to torpedo Australia's Pharmaceuticals Benefits Scheme, despite securing major concessions 20 years ago.
ABC News
Labor and Coalition vow PBS will not be bargained over in US trade war
Prime Minister Anthony Albanese and Opposition Leader Peter Dutton say the Pharmaceutical Benefits Scheme, a cornerstone of Australia's health system, will never be a negotiating chip in US President Donald Trump's ongoing tariff campaign.
ABC News
Big Pharma plea to Trump to punish Australia for cheaper medicines
US medical giants say Australia’s Pharmaceutical Benefits Scheme is an “egregious and discriminatory” program that Trump should target in the next wave of tariffs.
The Sydney Morning Herald